abstract |
The application describes an enantiomer, diastereoisomer or tautomer of a compound represented by formula (I) in which A, B, R, R, R, R, R, R, R, R, R and R are as defined herein, or a salt thereof or an ester as an inhibitor of HCV NS5B polymerase. |